Biographie

Ateudjieu

Jerome ATEUDJIEU is Associate Professor of Epidemiology and Public Health, Coordinator of  Master’s Program in Public Health and Epidemiology and Head of Department of Public Health at the Faculty of Medicine and Pharmaceutical Sciences; University of Dschang, Cameroon. He graduated in 1998 and 2008 as Medical Doctor and Public Health Specialist, respectively from the Faculty of Medicine and Biomedical Sciences of the University of Yaounde 1, Cameroon. He completed his PhD program in Epidemiology at Faculty of Sciences of the University of Basel in 2015. He is a founding member, president and Scientific Director of M.A. Santé (Meilleur Acces aux Soins de Santé), a Cameroon-based NGO.
His career in the health sector began with the position of general practitioner at the Kribi district hospital in 1998. Afterward, he successively served as Medical District Officer for Guéré and Mada health districts; Director of the Gueré District Hospital; deputy head of the Clinical Research unit; and Head of the Scientific Network unit at the Division of Operational Research in the Ministry of Public Health, Cameroon. He is a member of the Cameroon National Pharmacovigilance Commission and of Adverse Events Following Immunization Nation Expert committee.
He began his career in academia as assistant lecturer in the Faculty of Sciences of the University of Dschang in 2010 and progressed to the rank of lecturer in 2013 and associate professor of Epidemiology in 2019.  He has contributed to the training of more than 900 graduates in Biomedical Sciences, 150 medical student, 75 pharmacy students and supervised about 65 Maters thesis and medical doctor theses.
Prof. ATEUDJIEU research projects aim to test interventions that are expected to improve the efficiency and safety of routine and emergency protocols for preventive and curative health care, and prevention of environmental pollution.
Over the last 10 years, Prof. ATEUDJIEU has published over 50 original papers in peer-reviewed journals, contributed to 2 book chapters and founded Cameroon Health Research Forum (CaHReF). This biennial forum is an international conference that brings together interested partners and facilitates access of decision makers to health research results.

Publications

Ateudjieu Jérôme, Williams John, Hirtle Marie, Baume Cédric, Ikingura Joyce, Niaré Alassane, Sprumont Dominique

BACKGROUND: As actors with the key responsibility for the protection of human research participants, Research Ethics Committees (RECs) need to be competent and well-resourced in order to fulfil their roles. Despite recent programs designed to strengthen RECs in Africa, much more needs to be accomplished before these committees can function optimally. OBJECTIVE: To assess training needs for biomedical research ethics evaluation among targeted countries. METHODS: Members of RECs operating in three targeted African countries were surveyed between August and November 2007. Before implementing t Read more...

Armand Séraphin NKWESCHEU, Yves Ronny TSAGMO, Jerome ATEUDJIEU, Jean Louis ABENA FOE, Marcelline FOBA, Wilfred MBACHAM

Tuberculosis is a public health threat in Cameroon. Health Research was recently recognized by African Ministers of Health as an effective means of accelerating the control of any disease or health issue in Africa. Worldwide, research in the field of tuberculosis control has been promising. In the light of a rapidly changing global research environment it has therefore become timely to review and update the priorities for TB research. In Cameroon, research on TB is active and diversified but not carried out in a prioritized framework. It will therefore be interesting to assess this activity Read more...

Mbunka Muhamed Awolu, Jerome Ateudjieu, Eugène Joel Bayiha, Martin Yakum, CHEUGUEU DJIOTSOP Manuella, DOOH Herve Claude, Pierre Watho, Anne Bissek

Background: Cameroon is one of the countries with highest burden diabetes in Africa; the adequate respond of health personnel to this burden depend on their knowledge in preventing and managing diabetic patients. Objective: To assess the knowledge of health personnel on the management of diabetes mellitus in the West Region of Cameroon Study design: It was a cross sectional descriptive study conducted in the West Region of Cameroon from May to July 2016. The Knowledge of consulting health personnel, selected using a multi-stage random sampling, was assessed on diabetes prevention and manage Read more...

Charles Fokunang, Estella Tembe-Fokunang, Zacharia Sando, Marceline Ngounoue Djuidje, Barbara Atogho Tiedeu, Frederick Kechia, Jerome Ateudjieu, Valentin Ndikum, Raymond Langsi, Dobgima Fomnboh, Joseph Fokam, Luc Gwum, Obama Abena, Tazoacha Asongani, Vincent Pryde Titanji and Lazare Kaptue

The interest of migratory health displaced population and the impact on global disease epidemics has generated a lot of public health interest within the framework of movement in search for greener pastures. Many studies conducted to show a link between disease, travel and migration show some indications of historical connections that continue to have an impact on current medical programmes and daily activities [ Read more...

Projects

The primary aim of this project is to determine changes in the vibriocidal geometric mean titers (GMT) in subjects who receive the second dose of oral cholera vaccine (OCV) at different intervals: 2 weeks, 6 months, or 11 months following the first dose of vaccine. Secondary aims include a) vibriocidal antibody response rates in subjects who receive OCV at 2 weeks, 6 months, or 11 months following the first dose of vaccine, b) age specific serum vibriocidal GMTs following the second dose among participants given the second dose of OCV at intervals of 2 weeks, 6 months, or 11 months following the first dose of vaccine, c) GMT and antibody response rates of Immunoglobulin A (IgA) and Immunoglobulin G (IgG) anti-lipopolysaccharide (LPS) as measured by ELISA following the second dose among participants given the second dose of OCV at intervals of 2 weeks, 6 months, or 11 months following the first dose of vaccine. The hypothesis is that the vibriocidal GMT following the second dose, when given after 6 or 12 months will not be inferior to the response when the second dose is given according to the standard interval of two weeks. Learn more https://clinicaltrials.gov/ct2/show/NCT03719066

 

Jerome Ateudjieu of Meillerur Acces aux Soins de Sante in Cameroon will test whether training community volunteers to record demographic movements and monitor births and immunizations of residents and visitors in their villages can improve timely childhood vaccination coverage in Cameroon. Many health districts in Cameroon have reported outbreaks of vaccine-preventable diseases. One underlying cause is that many people in these regions travel extensively, making it difficult for health facilities to identify newborns that need vaccinating, and to inform parents when and where the necessary vaccinations can be received. They will select 60 villages in the Noun Health District of West Cameroon, and train community volunteers to record the movements and immunization status of infants up to 11 months in their village. These records will be sent by the WhatsApp mobile messaging application to the relevant health facility to identify the children eligible for the next immunization session. The necessary appointments will then be communicated back to the parents by the community worker, who will also inform them of the importance of timely immunization, and encourage pregnant mothers to give birth in health facilities.

Strengthening the capacity of investigators and members of ethics committees in Africa

Evaluer la qualité des données de routine dans le District de Santé de Dschang